Cocoa flavonoids protect hepatic cells against high-glucose-induced oxidative stress: relevance of MAPKs

Mol Nutr Food Res. 2015 Apr;59(4):597-609. doi: 10.1002/mnfr.201400492. Epub 2015 Feb 23.

Abstract

Scope: Oxidative stress plays a main role in the pathogenesis of type 2 diabetes mellitus. Cocoa and (-)-epicatechin (EC), a main cocoa flavanol, have been suggested to exert beneficial effects in type 2 diabetes mellitus because of their protective effects against oxidative stress and insulin-like properties. In this study, the protective effect of EC and a cocoa phenolic extract (CPE) against oxidative stress induced by a high-glucose challenge, which causes insulin resistance, was investigated on hepatic HepG2 cells.

Methods and results: Oxidative status, phosphorylated mitogen-activated protein kinases (MAPKs), nuclear factor E2 related factor 2 (Nrf2) and p-(Ser)-IRS-1 expression, and glucose uptake were evaluated. EC and CPE regulated antioxidant enzymes and activated extracellular-regulated kinase and Nrf2. EC and CPE pre-treatment prevented high-glucose-induced antioxidant defences and p-MAPKs, and maintained Nrf2 stimulation. The presence of selective MAPK inhibitors induced changes in redox status, glucose uptake, p-(Ser)- and total IRS-1 levels that were observed in CPE-mediated protection.

Conclusion: EC and CPE recovered redox status of insulin-resistant HepG2 cells, suggesting that the functionality in EC- and CPE-treated cells was protected against high-glucose-induced oxidative insult. CPE beneficial effects on redox balance and insulin resistance were mediated by targeting MAPKs.

Keywords: Antioxidant defences; Cocoa flavanols; HepG2 cells; Insulin resistance; Oxidative markers.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antioxidants / pharmacology
  • Cacao / chemistry*
  • Catechin / pharmacology
  • Diabetes Mellitus, Type 2 / drug therapy
  • Flavonoids / pharmacology*
  • Glucose / adverse effects*
  • Glutathione / metabolism
  • Glutathione Peroxidase / genetics
  • Glutathione Peroxidase / metabolism
  • Glutathione Reductase / genetics
  • Glutathione Reductase / metabolism
  • Hep G2 Cells
  • Hepatocytes / drug effects*
  • Humans
  • Hypoglycemic Agents / pharmacology
  • Insulin Receptor Substrate Proteins / genetics
  • Insulin Receptor Substrate Proteins / metabolism
  • Insulin Resistance
  • Mitogen-Activated Protein Kinases / genetics
  • Mitogen-Activated Protein Kinases / metabolism*
  • NF-E2-Related Factor 2 / genetics
  • NF-E2-Related Factor 2 / metabolism
  • Oxidative Stress / drug effects*
  • Phenols / pharmacology
  • Phosphorylation
  • Plant Extracts / pharmacology
  • Reactive Oxygen Species / metabolism
  • Up-Regulation

Substances

  • Antioxidants
  • Flavonoids
  • Hypoglycemic Agents
  • IRS1 protein, human
  • Insulin Receptor Substrate Proteins
  • NF-E2-Related Factor 2
  • NFE2L2 protein, human
  • Phenols
  • Plant Extracts
  • Reactive Oxygen Species
  • Catechin
  • Glutathione Peroxidase
  • Glutathione Reductase
  • Mitogen-Activated Protein Kinases
  • Glutathione
  • Glucose